Changes in the mRNA expression of osteoblast-related genes in response to β3-adrenergic agonist in UMR106 cells

Cell Biochemistry and Function

Volumn 28, Issue 1, 2010, Pages 45-51

  Nuntapornsak, Amporn ^a   Wongdee, Kannikar ^a,b   Thongbunchoo, Jirawan ^a   Krishnamra, Nateetip ^a   Charoenphandhu, Narattaphol ^a  

^a Mahidol University   (Thailand)

^b BURAPHA UNIVERSITY   (Thailand)

Author keywords

Adrenergic receptor; Alkaline phosphatase; Bone remodeling; Osteocalcin; Osteoprotegerin; Real time PCR

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; ADRENERGIC RECEPTOR; ALKALINE PHOSPHATASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR RUNX2;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL STRAIN UMR106; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EXPOSURE; DRUG RESPONSE; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; LOW DRUG DOSE; MINERALIZATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ADRENERGIC AGONISTS; ALKALINE PHOSPHATASE; ANIMALS; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOWN-REGULATION; FEMALE; HOMEODOMAIN PROTEINS; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-3; RNA, MESSENGER; TRANSCRIPTION FACTORS;

RATTUS;

EID: 74049109715     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1617     Document Type: Article

References (34)

1. Serre CM, Farlay D, Delmas PD, Chenu C. Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 1999; 25: 623-629.
2. Aitken SJ, Landao-Bassonga E, Ralston SH, Idris AI. β2- Adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. Arch Biochem Biophys 2009; 482: 96-103.
3. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 2008; 473: 231-236.
4. Pierroz DD, Bouxsein ML, Rizzoli R, Ferrari SL. Combined treatment with a β-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Bone 2006; 39: 260-267.
5. Takeuchi T, Tsuboi T, Arai M, Togari A. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 2001; 61: 579-586.
6. Yirmiya R, Goshen I, Bajayo A, et al. Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci USA 2006; 103: 16876-16881.
7. 2-adrenergic receptors in human osteoblasts. J Cell Physiol 2009; 220: 267-275.
8. Bonnet N, Laroche N, Vico L, Dolleans E, Benhamou CL, Courteix D. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther 2006; 318: 1118-1127.
9. 1-Adrenergic receptor stimulation induces the expression of receptor activator of nuclear factor κB ligand gene via protein kinase C and extracellular signal-regulated kinase pathways in MC3T3-E1 osteoblast-like cells. Arch Oral Biol 2007; 52: 778-785.
10. Bouxsein ML, Devlin MJ, Glatt V, Dhillon H, Pierroz DD, Ferrari SL. Mice lacking β-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy. Endocrinology 2009; 150: 144-152.
11. 3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 1995; 289: 223-228.
12. 3-adrenoceptors within the enteric nervous system. Gastroenterology 2007; 133: 175-183.
13. 3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 1999; 23: 1057-1065.
14. 3- adrenoceptors in human colon. Br J Pharmacol 1997; 120: 1527-1535.
15. 3-adrenergic receptors stimulate glucose uptake in brown adipocytes by two mechanisms independently of glucose transporter 4 translocation. Endocrinology 2006; 147: 5730-5739.
16. Charoenphandhu N, Teerapornpuntakit J, Methawasin M, Wongdee K, Thongchote K, Krishnamra N. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats. Can J Physiol Pharmacol 2008; 86: 240-248.
17. Wongdee K, Pandaranandaka J, Teerapornpuntakit J, et al. Osteoblasts express claudins and tight junction associated proteins. Histochem Cell Biol 2008; 130: 79-90.
18. 3-adrenoceptor agonist BRL 37344. J Pharmacol Exp Ther 1996; 277:22-27.
19. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006; 99: 1233-1239.
20. Lee MH, Kim YJ, Yoon WJ, et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 2005; 280: 35579-35587.
21. Jung C, Ou YC, Yeung F, Frierson HF Jr, Kao C. Osteocalcin is incompletely spliced in non-osseous tissues. Gene 2001; 271: 143-150.
22. Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990; 143: 420-430.
23. Bonnet N, Pierroz DD, Ferrari SL. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J Musculoskelet Neuronal Interact 2008; 8: 94-104.
24. Bonnet N, Benhamou CL, Malaval L, et al. Low dose β-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol 2008; 217: 819-827.
25. 2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J Cell Physiol 2009; 218: 268-275.
26. Kellenberger S, Muller K, Richener H, Bilbe G. Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating β2-adrenergic receptors. Bone 1998; 22: 471-478.
27. Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS. The cell biology of bone metabolism. J Clin Pathol 2008; 61: 577-587.
28. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000; 289: 1501-1504.
29. Lin JM, Callon KE, Lin JS, et al. Actions of fibroblast growth factor-8 in bonecells invitro.AmJPhysiolEndocrinolMetab2009;297: E142-E150.
30. Liu W, Toyosawa S, Furuichi T, et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 2001; 155: 157-166.
31. Schroeder TM, Jensen ED,Westendorf JJ. Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 2005; 75: 213-225.
32. Cao Y, Zhou Z, de Crombrugghe B, et al. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. Cancer Res 2005; 65: 1124-1128.
33. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29.
34. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM. The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 2001; 16: 1015-1027.